Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Osigraft Study in instrumented posterolateral lumbar fusion
NL-OMON19983Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Jul 2004
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of bone morphogenetic protein 7 in degenerative spondylolisthesis (DS), Isthmic spondylolisthesis and degenerative disc disease (DDD) (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Overall treatment success. Started Jul 2004; status: active, not recruiting.
02
Drugs
bone morphogenetic protein 7
03
Conditions
degenerative spondylolisthesis (DS)Isthmic spondylolisthesisdegenerative disc disease (DDD)
Beyond the preview
Go deeper on NL-OMON19983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON19983.